- Home
- Publications
- Publication Search
- Publication Details
Title
Focus on zavegepant: the first intranasal third-generation gepant
Authors
Keywords
-
Journal
Pain Management
Volume 12, Issue 8, Pages 879-885
Publisher
Future Medicine Ltd
Online
2022-10-03
DOI
10.2217/pmt-2022-0054
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preclinical Characterization of Antinociceptive Effect of Bergamot Essential Oil and of Its Fractions for Rational Translation in Complementary Therapy
- (2022) Damiana Scuteri et al. Pharmaceutics
- Pain and agitation treatment in severe dementia patients: The need for Italian Mobilization–Observation–Behavior–Intensity–Dementia (I-MOBID2) pain scale translation, adaptation and validation with psychometric testing
- (2022) D. Scuteri et al. BIOMEDICINE & PHARMACOTHERAPY
- Small molecule CGRP receptor antagonists for the preventive treatment of migraine: A review
- (2022) Jéssica Barreto Ribeiro dos Santos et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Real world considerations for newly approved CGRP receptor antagonists in migraine care
- (2022) Damiana Scuteri et al. Expert Review of Neurotherapeutics
- Gepants — a long way to cure: a narrative review
- (2022) Claudia Altamura et al. NEUROLOGICAL SCIENCES
- Comparing the Liver Safety Profiles of 4 Next-Generation CGRP Receptor Antagonists to the Hepatotoxic CGRP Inhibitor Telcagepant Using Quantitative Systems Toxicology Modeling
- (2022) Jeffrey L Woodhead et al. TOXICOLOGICAL SCIENCES
- Translational Value of the Transdermal Administration of Bergamot Essential Oil and of Its Fractions
- (2022) Damiana Scuteri et al. Pharmaceutics
- Rates of Response to Atogepant for Migraine Prophylaxis Among Adults
- (2022) Richard B. Lipton et al. JAMA Network Open
- Ictal and interictal brain activation in episodic migraine: Neural basis for extent of allodynia
- (2021) Nasim Maleki et al. PLoS One
- Development and Translation of NanoBEO, a Nanotechnology-Based Delivery System of Bergamot Essential Oil Deprived of Furocumarins, in the Control of Agitation in Severe Dementia
- (2021) Damiana Scuteri et al. Pharmaceutics
- Effects of Intravenous Eptinezumab vs Placebo on Headache Pain and Most Bothersome Symptom When Initiated During a Migraine Attack
- (2021) Paul K. Winner et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy
- (2021) Damiana Scuteri et al. JOURNAL OF HEADACHE AND PAIN
- Potassium channel openers — novel triggers of aura and migraine
- (2021) Alan M. Rapoport et al. Nature Reviews Neurology
- Atogepant for the Preventive Treatment of Migraine
- (2021) Jessica Ailani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bergamot rehabilitation AgaINst agitation in dementia ( BRAINAID ): Study protocol for a randomized, double‐blind, placebo‐controlled trial to assess the efficacy of furocoumarin‐free bergamot loaded in a nanotechnology‐based delivery system of the essential oil in the treatment of agitation in elderly affected by severe dementia
- (2021) Damiana Scuteri et al. PHYTOTHERAPY RESEARCH
- Progress in the Treatment of Migraine Attacks: From Traditional Approaches to Eptinezumab
- (2021) Damiana Scuteri et al. Pharmaceuticals
- 3CLpro and PLpro affinity, a docking study to fight COVID19 based on 900 compounds from PubChem and literature. Are there new drugs to be found?
- (2021) Marek Štekláč et al. JOURNAL OF MOLECULAR STRUCTURE
- Blocking the CGRP Pathway for Acute and Preventive Treatment of Migraine: The Evolution of Success
- (2020) Gene M. Dubowchik et al. JOURNAL OF MEDICINAL CHEMISTRY
- Glabridin Alleviates Inflammation and Nociception in Rodents by Activating BKCa Channels and Reducing NO Levels
- (2020) Ali Parlar et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Role of 5-HT1A Receptor in the Anxiolytic-Relaxant Effects of Bergamot Essential Oil in Rodent
- (2020) Laura Rombolà et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- An unexpected and suspended time
- (2020) Paolo Martelletti JOURNAL OF HEADACHE AND PAIN
- Effects of Aging on Formalin-Induced Pain Behavior and Analgesic Activity of Gabapentin in C57BL/6 Mice
- (2020) Damiana Scuteri et al. Frontiers in Pharmacology
- Gepants, calcitonin-gene-related peptide receptor antagonists: what could be their role in migraine treatment?
- (2020) David Moreno-Ajona et al. CURRENT OPINION IN NEUROLOGY
- Azepino-indazoles as calcitonin gene-related peptide (CGRP) receptor antagonists
- (2020) Stephen E. Mercer et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Pattern of treatment of behavioural and psychological symptoms of dementia and pain: evidence on pharmacoutilization from a large real-world sample and from a centre for cognitive disturbances and dementia
- (2020) Damiana Scuteri et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Global Burden of Headache Disorders in Children and Adolescents 2007–2017
- (2020) Matilde Leonardi et al. International Journal of Environmental Research and Public Health
- Opioids in Post-stroke Pain: A Systematic Review and Meta-Analysis
- (2020) Damiana Scuteri et al. Frontiers in Pharmacology
- Shaping the future of migraine targeting Calcitonin-Gene-Related-Peptide with the Disease-Modifying Migraine Drugs (DMMDs)
- (2019) Paolo Martelletti et al. JOURNAL OF HEADACHE AND PAIN
- New Trends in Migraine Pharmacology: Targeting Calcitonin Gene–Related Peptide (CGRP) With Monoclonal Antibodies
- (2019) Damiana Scuteri et al. Frontiers in Pharmacology
- Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial
- (2019) Robert Croop et al. LANCET
- Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine
- (2019) Richard B. Lipton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine
- (2019) Richard B. Lipton et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Ubrogepant for the Treatment of Migraine
- (2019) David W. Dodick et al. NEW ENGLAND JOURNAL OF MEDICINE
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
- (2018) CEPHALALGIA
- Quantitative Systems Toxicology Analysis of In Vitro Mechanistic Assays Reveals Importance of Bile Acid Accumulation and Mitochondrial Dysfunction in TAK-875-induced Liver Injury
- (2018) Diane M Longo et al. TOXICOLOGICAL SCIENCES
- Blocking CGRP in migraine patients – a review of pros and cons
- (2017) Marie Deen et al. JOURNAL OF HEADACHE AND PAIN
- Pathophysiology of Migraine: A Disorder of Sensory Processing
- (2017) Peter J. Goadsby et al. PHYSIOLOGICAL REVIEWS
- Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis
- (2016) Zsolt Hepp et al. CEPHALALGIA
- Migraine biomarkers in cerebrospinal fluid: A systematic review and meta-analysis
- (2016) Robin M van Dongen et al. CEPHALALGIA
- Application of a Mechanistic Model to Evaluate Putative Mechanisms of Tolvaptan Drug-Induced Liver Injury and Identify Patient Susceptibility Factors
- (2016) Jeffrey L. Woodhead et al. TOXICOLOGICAL SCIENCES
- Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis
- (2015) Chris Cameron et al. HEADACHE
- Discovery of (R)-N-(3-(7-methyl-1H-indazol-5-yl)-1-(4-(1-methylpiperidin-4-yl)-1-oxopropan-2-yl)-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide (BMS-742413): A potent human CGRP antagonist with superior safety profile for the treatment of migraine through intranasal delivery
- (2013) Prasad V. Chaturvedula et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Migraine in the elderly: clinical characteristics in a series of 71 cases
- (2013) S Herrero et al. JOURNAL OF HEADACHE AND PAIN
- Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity
- (2013) Dimitris N. Xanthos et al. NATURE REVIEWS NEUROSCIENCE
- Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: Table 1
- (2012) S.D. Silberstein et al. NEUROLOGY
- Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine
- (2011) David J Hewitt et al. CEPHALALGIA
- Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion
- (2010) S. Eftekhari et al. NEUROSCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started